Orchid Pharma Penalized by NSE and BSE Over Regulation 34 Non-Compliance
Orchid Pharma Ltd 路 Others (Uncategorized) 路 17 Nov 2026, 12:54 am
Orchid Pharma Penalized by NSE and BSE Over Regulation 34 Non-Compliance NSE and BSE levied a fine of Rs 2,000 each (plus 18% GST, totaling Rs 2,360 each) on Orchid Pharma for a one-day delay in submitting its Annual Report for FY25-26 under Regulation 34 of SEBI LODR Regulations. The Board of Directors noted the notices on 16th Nov'26, confirmed the payment of the imposed fines, and advised management to strengthen internal compliance monitoring mechanisms to prevent future statutory filing delays.
Original exchange filing (PDF)
More announcements from Orchid Pharma Ltd
- Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited ('the Company') 路 18 Nov 2026
- Investor Presentation-Quarter II of FY 2026-27, ended on September 30, 2026 路 17 Nov 2026
- Statement of deviation or variation for the quarter ended on September 30, 2026 on the use of proceeds of funds raised through Qualified institutional placement (QIP) 路 14 Nov 2026
- Declaration of Financial results for quarter and half year ended on September 30, 2026 路 14 Nov 2026
- Outcome of Board Meeting 路 14 Nov 2026
- Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Monitoring Agency Report for the Quarter-II ended on September 30, 2026 路 14 Nov 2026
- Intimation of schedule of Analysts/ Investors Earning Call for the Ouarter-II of F.Y. 2026-27 ended on September 30, 2026 路 17 Nov 2026
